메뉴 건너뛰기




Volumn 20, Issue 19, 2009, Pages 2201-2204

A short approach to the synthesis of the ritonavir and lopinavir core and its C-3 epimer via cross metathesis

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDE; LOPINAVIR; PROTEINASE INHIBITOR; RITONAVIR; TERT BUTYL 1 PHENYLBUT 3 EN 2 YL CARBAMATE; TERT BUTYL 1,6 DIPHENYLHEX 3 ENE 2,5 DIYLCARBAMATE; TERT BUTYL 3 HYDROXY 1,6 DIPHENYLHEXANE 2,5 DIYLDICARBAMATE; TERT BUTYL 3 HYDROXY 1,6 DIPHENYLHEXANE 2,5 DIYLDICARBAMATE 3; TERT BUTYL 3 OXO 1,6 DIPHENYLHEXANE 2,5 DIYLDICARBAMATE; UNCLASSIFIED DRUG;

EID: 72049119880     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2009.09.003     Document Type: Article
Times cited : (15)

References (47)
  • 8
    • 72049098362 scopus 로고    scopus 로고
    • Recently Abbott laboratories received U.S. F.D.A. approval for new lower-strength Kaletra (R) (lopinavir/ritonavir) tablet for Pediatric HIV Patients. Bio-Medicine news 11-12-2007.
    • Recently Abbott laboratories received U.S. F.D.A. approval for new lower-strength Kaletra (R) (lopinavir/ritonavir) tablet for Pediatric HIV Patients. Bio-Medicine news 11-12-2007.
  • 27


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.